299 related articles for article (PubMed ID: 11937526)
1. In vivo triggering through 4-1BB enables Th-independent priming of CTL in the presence of an intact CD28 costimulatory pathway.
Diehl L; van Mierlo GJ; den Boer AT; van der Voort E; Fransen M; van Bostelen L; Krimpenfort P; Melief CJ; Mittler R; Toes RE; Offringa R
J Immunol; 2002 Apr; 168(8):3755-62. PubMed ID: 11937526
[TBL] [Abstract][Full Text] [Related]
2. A switch in costimulation from CD28 to 4-1BB during primary versus secondary CD8 T cell response to influenza in vivo.
Bertram EM; Dawicki W; Sedgmen B; Bramson JL; Lynch DH; Watts TH
J Immunol; 2004 Jan; 172(2):981-8. PubMed ID: 14707071
[TBL] [Abstract][Full Text] [Related]
3. Defective T cell priming associated with aging can be rescued by signaling through 4-1BB (CD137).
Bansal-Pakala P; Croft M
J Immunol; 2002 Nov; 169(9):5005-9. PubMed ID: 12391215
[TBL] [Abstract][Full Text] [Related]
4. Temporal segregation of 4-1BB versus CD28-mediated costimulation: 4-1BB ligand influences T cell numbers late in the primary response and regulates the size of the T cell memory response following influenza infection.
Bertram EM; Lau P; Watts TH
J Immunol; 2002 Apr; 168(8):3777-85. PubMed ID: 11937529
[TBL] [Abstract][Full Text] [Related]
5. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.
Cannons JL; Lau P; Ghumman B; DeBenedette MA; Yagita H; Okumura K; Watts TH
J Immunol; 2001 Aug; 167(3):1313-24. PubMed ID: 11466348
[TBL] [Abstract][Full Text] [Related]
6. Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand: synergy with the CD28 co-stimulatory pathway.
Melero I; Bach N; Hellström KE; Aruffo A; Mittler RS; Chen L
Eur J Immunol; 1998 Mar; 28(3):1116-21. PubMed ID: 9541607
[TBL] [Abstract][Full Text] [Related]
7. Role of CD4 T cell help and costimulation in CD8 T cell responses during Listeria monocytogenes infection.
Shedlock DJ; Whitmire JK; Tan J; MacDonald AS; Ahmed R; Shen H
J Immunol; 2003 Feb; 170(4):2053-63. PubMed ID: 12574376
[TBL] [Abstract][Full Text] [Related]
8. Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients.
Blazar BR; Kwon BS; Panoskaltsis-Mortari A; Kwak KB; Peschon JJ; Taylor PA
J Immunol; 2001 Mar; 166(5):3174-83. PubMed ID: 11207270
[TBL] [Abstract][Full Text] [Related]
9. 4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function.
Wen T; Bukczynski J; Watts TH
J Immunol; 2002 May; 168(10):4897-906. PubMed ID: 11994439
[TBL] [Abstract][Full Text] [Related]
10. Role of 4-1BB (CD137) in the functional activation of cord blood CD28(-)CD8(+) T cells.
Kim YJ; Brutkiewicz RR; Broxmeyer HE
Blood; 2002 Nov; 100(9):3253-60. PubMed ID: 12384425
[TBL] [Abstract][Full Text] [Related]
11. CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand.
Saoulli K; Lee SY; Cannons JL; Yeh WC; Santana A; Goldstein MD; Bangia N; DeBenedette MA; Mak TW; Choi Y; Watts TH
J Exp Med; 1998 Jun; 187(11):1849-62. PubMed ID: 9607925
[TBL] [Abstract][Full Text] [Related]
12. Cooperation between 4-1BB and ICOS in the immune response to influenza virus revealed by studies of CD28/ICOS-deficient mice.
Vidric M; Suh WK; Dianzani U; Mak TW; Watts TH
J Immunol; 2005 Dec; 175(11):7288-96. PubMed ID: 16301634
[TBL] [Abstract][Full Text] [Related]
13. Role of TNF receptor-associated factor 2 and p38 mitogen-activated protein kinase activation during 4-1BB-dependent immune response.
Cannons JL; Choi Y; Watts TH
J Immunol; 2000 Dec; 165(11):6193-204. PubMed ID: 11086053
[TBL] [Abstract][Full Text] [Related]
14. Modulation of cord blood CD8+ T-cell effector differentiation by TGF-beta1 and 4-1BB costimulation.
Kim YJ; Stringfield TM; Chen Y; Broxmeyer HE
Blood; 2005 Jan; 105(1):274-81. PubMed ID: 15353478
[TBL] [Abstract][Full Text] [Related]
15. 4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses.
Shuford WW; Klussman K; Tritchler DD; Loo DT; Chalupny J; Siadak AW; Brown TJ; Emswiler J; Raecho H; Larsen CP; Pearson TC; Ledbetter JA; Aruffo A; Mittler RS
J Exp Med; 1997 Jul; 186(1):47-55. PubMed ID: 9206996
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and immunological characteristics of 4-1BB (CD137) receptor and ligand and potential applications in cancer therapy.
Sica G; Chen L
Arch Immunol Ther Exp (Warsz); 1999; 47(5):275-9. PubMed ID: 10604232
[TBL] [Abstract][Full Text] [Related]
17. Analysis of 4-1BB ligand (4-1BBL)-deficient mice and of mice lacking both 4-1BBL and CD28 reveals a role for 4-1BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus.
DeBenedette MA; Wen T; Bachmann MF; Ohashi PS; Barber BH; Stocking KL; Peschon JJ; Watts TH
J Immunol; 1999 Nov; 163(9):4833-41. PubMed ID: 10528184
[TBL] [Abstract][Full Text] [Related]
18. Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of experimental autoimmune encephalomyelitis.
Sun Y; Lin X; Chen HM; Wu Q; Subudhi SK; Chen L; Fu YX
J Immunol; 2002 Feb; 168(3):1457-65. PubMed ID: 11801689
[TBL] [Abstract][Full Text] [Related]
19. 4-1BB and OX40 act independently to facilitate robust CD8 and CD4 recall responses.
Dawicki W; Bertram EM; Sharpe AH; Watts TH
J Immunol; 2004 Nov; 173(10):5944-51. PubMed ID: 15528328
[TBL] [Abstract][Full Text] [Related]
20. Activation of resting human primary T cells with chimeric receptors: costimulation from CD28, inducible costimulator, CD134, and CD137 in series with signals from the TCR zeta chain.
Finney HM; Akbar AN; Lawson AD
J Immunol; 2004 Jan; 172(1):104-13. PubMed ID: 14688315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
